欢迎来到广东红珊瑚药业有限公司!
    Hotline:0769-22898885
A
About Us BOUT US
Your current location:HOME -> About Us -> Introduction

Founded in July 1998, Guangdong Hongshanhu Pharmaceutical Co.Ltd. (hereafter “Hongshanhu”) is a foreign capital medicine manufacturer that integrates research, development, production and distribution of medicine and healthcare products. Hongshanhu is a high-tech company with a registered capital of 45 million RMB, and is solely invested by Huiji International Pharmaceutical Ltd.

 

Hongshanhu has two modern production bases. One is located in the national economic and technology development zone in Zhanjiang, a beautiful coastal city by the South Sea of China. This base has a total area of more than10, 000 square meters, including a GMP standard workshop with an area of over 7000 square meters. This workshop has granule, tablet, and capsule production lines with the capability of manufacturing 50 million bags of granule, 200 million tablets, and 100 million capsules. The other base lies in the Donggaun Songshan Lake High-tech Development Zone. The first stage of construction of this base occupies an area of 66,700 square meters with a building area of 9000 square meters, and five production lines: tablet line, granule line, capsule line, pig blood extraction line, and Chinese medicine extraction line. The annual capability of this base is: 1 billion capsules, 500 million tablets, and 150 million bags of granule.

 

Hongshanhu currently has 216 employees, more than 43% of whom are high and medium-level science and technology talents with doctoral, master’s, and bachelor’s degrees, providing strong technology support to the development of Hongshanhu. Currently, the middle-high titled talents account for 6% of all employees.

 

Qi Replenishing and Blood Enriching Granule (QRBEG), Qi Replenishing and Blood Enriching Capsule (QRBEC), Qi Replenishing and Blood Enriching Tablet (QRBET), Kidney Nourishing and Blood Enriching Granule (KNBEG), and Liver Cleaning Granule (a heat-clearing and diuresis-promoting drug) are the five Chinese medicine patents and intellectual properties exclusively owned by Hongshanhu. Our three leading products: Qi Replenishing and Blood Enriching Granule (QRBEG), Qi Replenishing and Blood Enriching Capsule (QRBEC), Qi Replenishing and Blood Enriching Tablet (QRBET), and Kidney Nourishing and Blood Enriching Granule (KNBEG) gained good reputation among blood enriching products because of their unique functions and significant effectiveness, making these products very popular among medicine professionals and consumers.

 

Hongshanhu attaches great importance to technology innovation and research and development.

Encouraged by the three invention patents we have, Hongshanhu invests a large amount on research and development, and widely employs science and technology talents. Also, we actively apply science and technology projects, put more efforts into research and development of new products, and emphasize more on property rights protection. Several of our products have been listed as the national torch project by the National Science and Technology Commission and Guangdong Province Science and Technology Commission, and have won many awards, such as the National New Products, Guangdong Province Science and Technology Progress, and Zhanjing Science and Technology Process.

 

Looking forward to the future, we will adhere to our core values: loyalty, gratitude, harmony and responsibility; insist on accomplishing our mission to contribute our best to people’s health; and further develop our spirit of integrity, pragmatism, learning, and innovation. Also, we will focus more on sustainable innovation, implement advanced talent strategy, improve our quality management, and further enhance our competitive ability in order to continue to make contributions to people’s health and well being, to take more social responsibilities, and to achieve our own brilliant success.